A5072526524- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Colorectal and Anal Carcinomas
- Genetic factors in colorectal cancer
Queen's University
2024
Abstract Purpose: Sidedness is prognostic and predictive of anti-EGFR efficacy in metastatic colorectal cancer (mCRC). Transverse colon has been historically excluded from several analyses sidedness the optimal division between left- right-sided unclear. We investigated transverse primary tumor location as a biomarker mCRC. Experimental Design: Pooled analysis CCTG/AGITG CO.17 CO.20 trials cetuximab chemotherapy-refractory Outcomes patients with RAS/BRAF wild-type (WT) mCRC KRAS WT were...
<p>Supplementary data</p>
<p>Supplementary data</p>
<div>AbstractPurpose:<p>Sidedness is prognostic and predictive of anti-EGFR efficacy in metastatic colorectal cancer (mCRC). Transverse colon has been historically excluded from several analyses sidedness the optimal division between left- right-sided unclear. We investigated transverse primary tumor location as a biomarker mCRC.</p>Experimental Design:<p>Pooled analysis CCTG/AGITG CO.17 CO.20 trials cetuximab chemotherapy-refractory mCRC. Outcomes patients with...
<div>AbstractPurpose:<p>Sidedness is prognostic and predictive of anti-EGFR efficacy in metastatic colorectal cancer (mCRC). Transverse colon has been historically excluded from several analyses sidedness the optimal division between left- right-sided unclear. We investigated transverse primary tumor location as a biomarker mCRC.</p>Experimental Design:<p>Pooled analysis CCTG/AGITG CO.17 CO.20 trials cetuximab chemotherapy-refractory mCRC. Outcomes patients with...